Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: In vivo, in vitro and in silico studies

被引:10
|
作者
Li, Xin [1 ]
He, Sen [1 ]
Xiao, Han [2 ]
He, Ting-Ting [1 ]
Zhang, Jia-Da [1 ]
Luo, Zi-Rui [1 ]
Ma, Jie-Zhi [3 ]
Yin, Yu-Long [1 ]
Luo, Lin [1 ]
Cao, Lin-Ying [1 ]
机构
[1] Hunan Agr Univ, Coll Resources & Environm, 1 Nongda Rd, Changsha 410128, Peoples R China
[2] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China
[3] Cent South Univ, Xiangya Hosp 3, Dept Obstet & Gynecol, Changsha 410013, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Neonicotinoid insecticides; G protein-coupled receptor; Estrogenic disruption effect; Breast cancer; Signal pathway; Molecular initiation event; SURFACE-WATER; BISPHENOL-A; EXPOSURE; EXPRESSION; GPER; PESTICIDES; MECHANISM; TOXICITY; GPR30; CELLS;
D O I
10.1016/j.envint.2022.107568
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Neonicotinoid insecticides (NIs) have been widely detected in environmental media and human body with concentrations reaching hundreds of nanomolar to micromolar levels. However, the information about their human health toxicology and mechanism is deficient. Previous studies have implied that NIs might exert es-trogenic disruption and promote breast cancer progression, but the molecular mechanism is unclear, especially the molecular initiating event. G protein-coupled estrogen receptor (GPER), as a candidate therapeutic target, plays vital roles in the development of breast cancer. This work aimed to reveal the potential mechanism through GPER pathway. Firstly, we screened the activities of seven most common NIs on GPER signal pathway by calcium mobilization assay. Clothianidin, acetamiprid (ACE), and dinotefuran activated GPER most potently and ACE displayed the highest agonistic activity with the lowest observed effective concentration (LOEC) of 1 mu M. The molecular docking and dynamics simulation showed favored interaction trend between the NIs and GPER. The three NIs with GPER activity induced 4T1 breast cancer cells migration and ACE showed the highest potency with LOEC of 100 nM. ACE also induced 4T1 cells proliferation at high concentration of 50 mu M and up-regulated GPER expression in a dose-dependent manner. We speculated that both the induction effects of ACE on 4T1 cells proliferation and migration might be owing to the activation and up-regulation of GPER. By using 4T1-Luc cells injected orthotopic tumor model, we found that ACE also promoted in-situ breast cancer growth and lung metastasis in normal mouse dependent on GPER. However, ACE only promoted in-situ breast cancer growth through GPER but not lung metastasis in ovariectomized mice, implying that the ACE-induced lung metastasis should be related to endogenous estrogen from ovary. Overall, we demonstrated that NIs promoted breast cancer progression via GPER pathway at human related exposure levels and their female health risks need urgent concerns.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Identification of G protein-coupled estrogen receptor in human and pig spermatozoa
    Rago, V.
    Giordano, F.
    Brunelli, E.
    Zito, D.
    Aquila, S.
    Carpino, A.
    JOURNAL OF ANATOMY, 2014, 224 (06) : 732 - 736
  • [22] Chrysin-Induced G Protein-Coupled Estrogen Receptor Activation Suppresses Pancreatic Cancer
    Lim, Hyun Kyung
    Kwon, Hee Jung
    Lee, Ga Seul
    Moon, Jeong Hee
    Jung, Joohee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [23] G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer
    Dragan, Magdalena
    Nguyen, Mai-Uyen
    Guzman, Stephania
    Goertzen, Cameron
    Brackstone, Muriel
    Dhillo, Waljit S.
    Bech, Paul R.
    Clarke, Sophie
    Abbara, Ali
    Tuck, Alan B.
    Hess, David A.
    Pine, Sharon R.
    Zong, Wei-Xing
    Wondisford, Frederic E.
    Su, Xiaoyang
    Babwah, Andy V.
    Bhattacharya, Moshmi
    CELL DEATH & DISEASE, 2020, 11 (02)
  • [24] G protein-coupled estrogen receptor activation by bisphenol-A disrupts lipid metabolism and induces ferroptosis in the liver
    He, Wanqiu
    Gao, Zhangshan
    Liu, Shuhui
    Tan, Lei
    Wu, Yuting
    Liu, Jiwen
    Zheng, Ziyi
    Fan, Wentao
    Luo, Yan
    Chen, Zeguo
    Song, Suquan
    ENVIRONMENTAL POLLUTION, 2023, 334
  • [25] Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
    Tutzauer, Julia
    Sjostrom, Martin
    Bendahl, Par-Ola
    Ryden, Lisa
    Ferno, Marten
    Leeb-Lundberg, L. M. Fredrik
    Alkner, Sara
    PLOS ONE, 2020, 15 (04):
  • [26] Immunolocalization of G protein-coupled estrogen receptor in the rat epididymis
    Martinez-Traverso, Griselle B.
    Pearl, Christopher A.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
  • [27] The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis
    Talia, Marianna
    De Francesco, Ernestina Marianna
    Rigiracciolo, Damiano Cosimo
    Muoio, Maria Grazia
    Muglia, Lucia
    Belfiore, Antonino
    Maggiolini, Marcello
    Sims, Andrew H.
    Lappano, Rosamaria
    CELLS, 2020, 9 (03)
  • [28] Upregulation of G Protein-Coupled Estrogen Receptor by Chrysin-Nanoparticles Inhibits Tumor Proliferation and Metastasis in Triple Negative Breast Cancer Xenograft Model
    Kim, Kyoung Mee
    Jung, Joohee
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [29] Immunolocalization of G protein-coupled estrogen receptor in the rat epididymis
    Griselle B. Martínez-Traverso
    Christopher A. Pearl
    Reproductive Biology and Endocrinology, 13
  • [30] Advances in immune regulation of the G protein-coupled estrogen receptor
    Dong, Hanzhi
    Zeng, Xiaoqiang
    Xu, Jiawei
    He, Chongwu
    Sun, Zhengkui
    Liu, Liyan
    Huang, Yanxiao
    Sun, Zhe
    Cao, Yuan
    Peng, Zhiqiang
    Qiu, Yu-an
    Yu, Tenghua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 136